Fitoestrogeny i izoflavonoidy soi v lechenii klimaktericheskogo sindroma
- Authors: Ledina A.V1, Prilepskaya V.N1
-
Affiliations:
- Issue: No 12 (2012)
- Pages: 86-89
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279716
- ID: 279716
Cite item
Open Access
Access granted
Abstract
The efficacy and tolerability of soy isoflavones, which have hormone-like effects, in the treatment of vasomotor and emotional and autonomic manifestations of the menopausal syndrome in postmenopausal women were evaluated. Patients received Inoclim containing 40 mg of soy isoflavones, 2 pills a day. Mean age - 52.7 ± 1.4 years, duration of treatment - 3 months. Kupperman index before treatment was 28.4 ± 1.7, after treatment - 15.6 points. After 3 months of treatment, 83.8 % of women reported a significant improvement in health, reduction of frequency and severity of hot flashes, sleep disturbances, which led to increased working ability. However, the short treatment period (3 months) suggests the feasibility for further research in this direction.
Keywords
Full Text
References
- Вихляева Е.М. Стратегия заместительной гормональной терапии при постменопаузальном синдроме / Гормональная коррекция системных изменений в менопаузе. Мат. симпозиум 10.04.1997. М., 1997. С. 22-34.
- Йорданов Д. и др. Фитотерапия. Мед. и физ. София, 1970. 342 с.
- Руководство по климактерию / Под ред. В.П. Сметник, В.И. Кулакова. М., 2001. 685 с.
- Breckwoldt M, et al. Benefits and risks of hormone replacement therapy. J Steroid Biochem Mol Biol 1995;53:205-8.
- Adams NR. Permanent infertility in ewes exposed to plant oestrogens. Aust Vet J 1990;67(6):197-201.
- Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997;29(2):95-120.
- Atmaca A, et al. Soy isoflavones in the management of postmenopausal osteoporosis. Menopause 2008; 15(4 Pt. 1):748-57.
- Chen J, et al. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. Pharmacol Exp Ther 2003;304(3): 1228-35.
- Demonty I, et al. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 2003;61 (6 Pt. 1):189-203.
- Duncan AM, et al. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 2003;17(2):253-71.
- Gu Y, et al. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol 2005; 11(41 ):6512-17.
- Jian L Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 2009;53(2):217-26.
- Kenneth DR, et al. Dietary Isoflavones: Biological Effects and Relevance to Human Health. J Nutr 1999;129:758-67.
- Krebs EE, et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104:824-36.
- Kris-Etherton PM, et al. Bioactive Compounds in Foods: Their Role in the Prevention of Cardiovascular Disease and cancer. Am J Med 2002;113(9B)30:71-88.
- Makela SI, et al. Dietary soybean may be antiestrogenic in male mice. J Nutr 1995; 125:43 7-45.
- Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 1998;12(4):729-42.
- Merz-Demlow BE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 2000;71(6): 1462-69.
- Nebe B, et al. Influence of phytoestrogens on the proliferation and expression of adhesion receptors in human mammary epithelial cells in vitro. Eur J Cancer Prev 2006; 15(5):405-15.
- Nelson HD, et al. Nonhormonal Therapies for Menopausal Hot Flashes. Systematic Review and Meta-analysis. JAMA 2006;295:2057-71.
- Nijveldt RJ, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25.
- Sha GH, Lin SQ. Genistein inhibits proliferation of human endometrial endothelial cell in vitro. Chin Med Sci J 2008;23( 1 ):49-53.
- Sommer B, et al. Attitudes toward menopause and aging across ethnic/racial groups. Psychosom Med 1999;61 (6):868- 75.
- Zumoff B. Biological and endocrinological insights into the possible breast cancer risk from postmenopausal estrogen replacement therapy. Steroids 1993;58:196-204.
Supplementary files
